I liked the news that Chiral will be contacting the 1400
I liked the news that Chiral will be contacting the 1400 hospitals to see if they want to stock Leronlimab in their hospitals. We know they are approved for 100 patients each or 400 doses. Future revenue that is substantial can’t be that far away.
I also liked the marketing agreements coming for strong partner in Europe and the Middle East soon.
The dominos are lining up... when will the first EUA fall and knock down the row of dominos giving us sales in all these countries we are aligning with these partnerships. Will it happen prior to interim results or will we have to wait for the interim results?
7
1
CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼
Top 10 Most Recent News Articles
Top 5 Most Recently Viewed Articles
Formula GT Global Launch Set to Transform Motorsport A remarkable dawn is heralded in the motorsport world as Formula GT officially announces its global launch, scheduled for Spring 2026. This groundbreaking league integrates advanced technology, high-speed capabilities, and the most prestigious hypercars, promising to redefine racing as we know it. Exciting Launch Gala...
Continue Reading
Understanding the Settlement Agreement Ultra Lithium Inc. has made headlines with its recent settlement agreement with Power Minerals Limited regarding their convertible loan agreement. This agreement comes after months of negotiations and aims to outline specific terms beneficial to both companies. Key Terms of the Agreement The settlement agreement involves several...
Continue Reading
Introducing the Revolutionary Sync Gold Series Typhur, a frontrunner in smart kitchen technology, is excited to announce its latest innovation: the Sync Gold Series wireless meat thermometers. These thermometers are built with cutting-edge Sub-1G technology, which takes your cooking precision to the next level. The Sync Gold Series features two versatile models: the Sync...
Continue Reading
Understanding AutoZone Inc's Short Interest AutoZone Inc (NYSE: AZO) has recently seen a noteworthy rise in its short interest, which now stands at approximately 5.91% higher than its previous report. This increase translates to around 317 thousand shares being sold short, representing 2.15% of the total regular shares available for trading. Given its trading patterns, it...
Continue Reading
Parex Resources Moves Forward with New Share Buyback Initiative Parex Resources Inc. (TSX: PXT) is excited to share its latest development, which involves a normal course issuer bid that has received approval from the Toronto Stock Exchange. The company aims to purchase up to 8,621,348 common shares, with a goal of enhancing shareholder value while demonstrating...
Continue Reading
